Non-surgical Aneurysm Therapy : AAvertTM
There is no known AAA treatment prior to surgical intervention, which is only indicated for those with larger diameter (>5.5cm), late stage aneurysmal disease. No one treats AAAs smaller than 5.5cm. The target patients of Vatrix are those dangerously waiting to become candidates for surgery. Vatrix can also provide a treatment option to those patients whose anatomies prohibit them from being surgical candidates.
Vatrix has developed a balloon delivery system with patented polymer coating for the direct treatment of aneurysmal tissue. AAvert serves to: 1) Halt the degenerative processes associated with aneurysms, and 2) Mechanically strengthen the arterial wall. In this way, AAvert directly hinders aneurysm-related dilation, thus substantially decreasing the risk of rupture, increasing the longevity of patients, and delaying or eliminating the need for more dangerous and traumatic surgical interventions.
